The successful development of new pharmaceutical agents often hinges on the efficient synthesis and thorough characterization of key intermediates. NINGBO INNO PHARMCHEM CO.,LTD. is at the forefront of providing these vital building blocks, including the complex molecule 4-(4-bromo-2-fluoroanilino)-6-methoxyquinazolin-7-one (CAS 196603-96-0). This compound is recognized for its significant utility in advanced chemical synthesis, particularly within the pharmaceutical industry.

The synthesis of 4-(4-bromo-2-fluoroanilino)-6-methoxyquinazolin-7-one typically involves multi-step organic reactions, often starting from more basic precursors. NINGBO INNO PHARMCHEM CO.,LTD. has refined synthesis protocols to ensure high yields and exceptional purity, meeting the demanding standards required for pharmaceutical applications. The process, often involving reactions under specific conditions such as reflux and purification via column chromatography, yields a product typically appearing as a white powder with a purity of ≥98.0%.

Characterization is as crucial as synthesis. Detailed spectral data, including Nuclear Magnetic Resonance (NMR) spectroscopy (¹H NMR and ¹³C NMR), is vital for confirming the structure and purity of the compound. These analyses provide definitive evidence of the molecular arrangement, ensuring that the intermediate is precisely as expected, which is critical for its subsequent use in complex syntheses. NINGBO INNO PHARMCHEM CO.,LTD. provides such characterization data to its clients, fostering confidence in product quality.

The application of 4-(4-bromo-2-fluoroanilino)-6-methoxyquinazolin-7-one as an intermediate for VEGFR2 imaging agents underscores its importance in the field of medical diagnostics, particularly in oncology. Researchers utilize this molecule to build sophisticated agents capable of visualizing specific biological targets within the body, offering non-invasive methods for disease detection and monitoring. This makes it a valuable component in the toolkit for anyone working on novel diagnostic and therapeutic strategies.

NINGBO INNO PHARMCHEM CO.,LTD. is committed to advancing scientific research by supplying high-quality intermediates. Our expertise in synthesis and characterization ensures that our clients receive reliable materials for their critical projects. For inquiries regarding the synthesis, characterization, or procurement of 4-(4-bromo-2-fluoroanilino)-6-methoxyquinazolin-7-one, we invite researchers to contact us.